NEW ERA IN MULTIPLE MYELOMA. CONSEQUENCES OF THE ARRIVAL OF NEW AGENTS

被引：0

作者：

Sobejano Fuertes, E. ^{[1
]}

Gonzalez, V ^{[1
]}

Higuero, V ^{[1
]}

Garcia-Sanz, R. ^{[1
]}

Presa, D. ^{[1
]}

Azibeiro, R. ^{[1
]}

Fonseca, M. ^{[1
]}

Rey, B. ^{[1
]}

Puig, N. ^{[1
]}

Gutierrez, N. ^{[1
]}

Leoz, P. ^{[1
]}

Labrador, J. ^{[2
]}

Aguilera, C. ^{[3
]}

Escalante, F. ^{[4
]}

Alonso Jose, M. ^{[5
]}

Lopez, R. ^{[6
]}

Garcia-Mateo, A. ^{[7
]}

Garcia de Coca, A. ^{[8
]}

Hernandez, R. ^{[9
]}

Barez, A. ^{[10
]}

Redondo, E. ^{[11
]}

Mateos, M., V ^{[1
]}

机构：

[1] Hosp Univ Salamanca, Salamanca, Spain

[2] Hosp Univ Burgos, Burgos, Spain

[3] Hosp Bierzo, Leon, Spain

[4] Hosp Univ Leon, Leon, Spain

[5] Hosp Rio Carr Palencia, Palencia, Spain

[6] Hosp Plasencia, Palencia, Spain

[7] Hosp Segovia, Segovia, Spain

[8] Hosp Clin Valladolid, Valladolid, Spain

[9] Complejo Asistencial Zamora, Zamora, Spain

[10] Hosp Nuestra Senora Sonsoles, Avila, Spain

[11] Fdn Hematol Castilla & Leon, Leon, Spain

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-021

引用

页码：20 / 21

页数：2

共 50 条

[21] Multiple myeloma: chemotherapy or transplantation in the era of new drugs
Palumbo, Antonio
Rajkumar, S. Vincent
EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (05) : 379 - 390
[22] Monoclonal antibodies - A new era in the treatment of multiple myeloma
Jelinek, Tomas
Hajek, Roman
BLOOD REVIEWS, 2016, 30 (02) : 101 - 110
[23] Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
Zhou, Xiang
Einsele, Hermann
Danhof, Sophia
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
[24] Multiple myeloma and kidney transplantation: the beginning of a new era
Van den bosch, Ines
Sprangers, Ben
Gertz, Morie
CLINICAL KIDNEY JOURNAL, 2019, 12 (02) : 213 - 215
[25] Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.
Witzig, TE
Gertz, MA
Lust, JA
Kyle, RA
OFallon, WM
Greipp, PR
BLOOD, 1995, 86 (10) : 217 - 217
[26] Drug resource use and costs for novel agents in multiple myeloma.
Binder, Gary
Harwin, William N.
Stemkowski, Stephen
Zhou, Yunping
Khan, Zeba M.
Nourbakhsh, Ali
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[27] Multiple Myeloma in the Era of Novel Agents Introduction
Dimopoulos, Meletios A.
Attal, Michel
SEMINARS IN HEMATOLOGY, 2009, 46 (02) : 107 - 109
[28] WHAT ARE THE NEW AGENTS IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MYELOMA?
Abonour, Rafat
LEUKEMIA RESEARCH, 2014, 38 : S14 - S15
[29] New Agents in Multiple Myeloma: An Examination of Safety Profiles
Bringhen, Sara
De Wit, Edwin
Dimopoulos, Meletios-Athanassios
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (07): : 391 - +
[30] Monoclonal antibodies for treating multiple myeloma - a new era, new safety considerations?
Oliva, Stefania
Palumbo, Antonio
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (10) : 1295 - 1300

← 1 2 3 4 5 →